Introduction
Acute Promyelocytic Leukemia (APL) has two distinguishing features: the PML/RARa chimeric gene, which results from a translocation involving the PML locus on chromosome 15 and the retinoic acid (RA) a receptor (RARa) locus on the 17; and the high sensitivity of the neoplastic cells to retinoids, which provides the cellular basis for the RAtreatment of APL patients (reviewed in Grignani et al., 1994) . PML/RARa transgenic mice demonstrated that the fusion protein is connected to both the pathogenesis and RA-sensitivity of the disease (Brown et al., 1997a; Grisolano et al., 1997; LiZhen et al., 1997) .
Several experimental ®ndings indicate that both the leukaemogenetic eect of PML/RARa and its ability to mediate RA-sensitivity are due to interference of the fusion protein with the program of terminal dierentiation: (i) before the onset of leukemias, the PML/RARa transgenic mice show a pre-leukemic condition characterized by increased and poorly dierentiated hematopoietic precursors in the bonemarrow (Brown et al., 1997a) ; (ii) expression of PML/ RARa in hematopoietic precursor cell lines blocks dierentiation induced by physiological stimuli (Grignani et al., 1993) ; (iii) RA induces differentiation of PML/RARa-expressing cells, both in the patients (Grignani et al., 1994) and in transgenic mice (Brown et al., 1997a; Grisolano et al., 1997; LiZhen et al., 1997) ; (iv) expression of PML/RARa in resistant or poorly RA-sensitive cell lines restores a dierentiative response to RA (Grignani et al., 1993; Ruthardt et al., 1997 ). It appears, therefore, that PML/RARa blocks dierentiation at physiological concentrations of RA, while it favours it at pharmacological doses.
The potential of PML/RARa to interfere with dierentiation is thought to involve transcriptional deregulation of RA-target genes. RARs are RAdependent transcription factors which, in adult hematopoietic cells, are involved in the control of terminal dierentiation (Tsai et al., 1994; Chambon, 1996) . Their target genes are, however, mostly unknown. In the absence of RA, RARs repress transcription by recruiting histone deacetylases (HD). Low levels of histone acetylation are thought to lead to a repressive chromatin conformation. RA releases HD from RARs and recruits multiple coactivators, thus resulting in activation of gene expression (Grunstein, 1997) . PML/RARa retains the ability of RARa to bind HD and to regulate transcription of RA-target genes. Indeed, the integrity of the PML/ RARa DNA-binding domain and of the PML/RARa-HD complex are essential for both the transcriptional regulation properties on RA-target genes and the eects on dierentiation of the fusion protein (Grignani et al., 1996; Lin et al., 1998) . The identi®cation of RA-inducible transcriptional targets is, therefore, crucial for the elucidation of the eects of the fusion protein on dierentiation.
In this paper, we demonstrate that p21 WAF1/CIP1 gene is directly regulated by PML/RARa and that its upregulation during the G1-to S phase transition is required for the capacity of the fusion protein to mediate dierentiation by RA. Our results shed new light onto the function of p21 during the process of commitment to terminal dierentiation.
Results
Commitment to dierentiation in PML/RARaexpressing cells occurs during the ®rst 24 h of RA-stimulation and coincides with the execution of one round of cell division Treatment with RA of PML/RARa-expressing cells induces degradation of the fusion protein within the ®rst 24 h through mechanisms that involve both the proteasome and the caspase pathways (Raelson et al., 1996; Yoshida et al., 1996; C Nervi et al., 1998-submitted) . The fact that PML/RARa is degraded by RA suggests that a relatively short period of time is required for the fusion protein to commit cells to dierentiation. To determine the duration of the commitment phase, we measured the time of RAtreatment sucient to induce dierentiation of PML/ RARa expressing cells. As a model system we chose the PR9 clone, obtained from the monoblastic U937 cell line by transfection of the PML/RARa cDNA under the control of the zinc (Zn)-inducible metallothionein promoter. Under basal conditions, PR9 cells do not dierentiate upon RA-treatment and the fusion protein is undetectable, while after Zn-treatment cells become responsive to RA-induced dierentiation and they express levels of PML/RARa which are comparable to those of APL fresh blasts (Grignani et al., 1993 and Figure 1 ). Zn-induced or uninduced PR9 cells were treated with pulses of RA for dierent time periods (2, 4, 8, 12, 24, 48, 72 or 96 h), extensively washed and then cultured in ligand-free medium. Dierentiation was measured for all samples after 96 h by testing their capacity to reduce nitroblue tetrazolium (NBT), a property associated with the phagocytic activity of mature monocytes (Grignani et al., 1993) . As shown in Figure 1a , PML/RARa-expressing cells achieved approximately 75 and 85% of the ®nal dierentiative response with RA-pulses of 12 and 24 h, respectively. Parallel Western blot analysis of PML/RARa expression showed that the fusion protein is markedly downregulated by 12 h, and it has almost completely disappeared by 24 h (Figure 1b) . Similar results were obtained using the APL-derived NB4 cell line (not shown). We conclude that commitment to differentiation occurs within the ®rst 24 h of RA-treatment and that this period coincides with the persistence of the fusion protein.
We next investigated the cellular events associated with the 24 h-commitment period and, as a ®rst approach, we compared the cell cycle properties of PR9 cells by¯ow cytometry of propidium iodide(PI)-stained nuclei. Cells were grown in four dierent culture conditions: either in the absence or presence of Zn and, in both cases, with or without RA. The relative percentages of cells in the G1, S and G2/M phases of the cell cycle, as revealed by FACS analysis, did not vary signi®cantly during the ®rst 24 h and under each of the four dierent culture conditions: all samples showed, on average, approximately 40% of replicating cells (see Figure 2a for representative results). It appears, therefore, that the period when commitment to dierentiation occurs (i.e. the ®rst 24 h) is not accompanied by G1 accumulation.
To extend these ®ndings at the single cell-level, we repeated the same type of experiment using synchronized cells. A 97% G1-pure population of PML/ RARa-expressing PR9 cells was obtained by centrifugal elutriation and cultured in the presence or absence of RA (Figure 2b ). Flow cytometry analysis of PIstained nuclei revealed that G1-elutriated PR9 cells synchronously progressed through a complete round of cell cycle during the ®rst 16 h of culture, regardless of the presence of RA (Figure 2b ). Similar results were obtained with control PR9 (i.e. PML/RARa nonexpressing) either in the presence or absence of RA (data not shown). We conclude that each single PML/ RARa-expressing cell, receiving RA-induction, moves through one complete mitotic cycle. The commitment period for RA-driven dierentiation, as de®ned by the wash-out experiment on asynchronous cells, entirely covers this cell cycle. Notably, we con®rmed that RAinduced dierentiation is also associated with cell division in the NB4 cell line and in one fresh sample of APL blasts (data not shown).
Transition from G1-to S phase is necessary for the dierentiative eect of RA on PML/RARa expressing cells
Since one round of cell-division is associated with the 24-h commitment period, we investigated whether inhibition of proliferation prevented RA-induced dierentiation of PML/RARa expressing cells. To this end, PR9 cells were treated with two dierent cell cycle inhibitors: mimosine or hydroxyurea. In these experiments, RA-induced dierentiation was monitored by measuring the levels of CD11a, a surface antigen Identical results were also obtained using the NB4 cell line (data not shown). Hydroxyurea-induced S phase block, instead, did not prevent RA-induced dierentiation in PML/RARa-expressing cells ( Figure  2d , right panel). Notably, dierentiation of PR9 cells was greatly enhanced by hydroxyurea treatment, as reported also for other S phase inhibitors (Bloch, 1993) . Considering that mimosine prevents the initiation of DNA replication in late G1, while hydroxyurea blocks the elongation step during S phase, these results suggest that the G1 to S transition is a crucial event for PML/RARa-and RA-dependent dierentiation.
PML/RARa induces a marked up-regulation of p21 WAF1/CIP1 in RA-treated cells To characterize at the molecular level the G1-S transition associated with RA-induced dierentiation of PML/RARa-expressing-cells, we next analysed the expression of a number of genes involved in cell-cycle regulation (cyclin A, cyclin E, p27, p21, p16, pRB, PCNA) in RA-treated PR9 cells, either expressing or not the fusion protein. p21 was the only gene whose expression was found to be markedly up-regulated in the presence of PML/RARa. The p21 transcript, as revealed by Northern blot analysis (Figure 3a ), was almost undetectable in control PR9 cells and slightly increased around the 6th hour of RA treatment. In contrast, it was strongly expressed in PML/RARa-cells from the 2nd to the 24th hour. At any given time point, the expression of PML/ RARa caused a 20 ± 30-fold up-regulation of p21 transcript ( Figure 3a) . Hybridization of the same Northern blots with probes derived from the other cell-cycle genes revealed no dierences between PML/ RARa-expressing and non-expressing cells (see Figure  3a for the p16 hybridization). Western blotting analysis of p21 expression revealed a parallel increase of p21 protein in RA-treated PML/RARa expressing cells, detectable as early as 4 h after RA-treatment ( Figure  3b ). Comparable results were obtained in the NB4 cell line (Figure 3b ).
Since p21 contains a functional RA-responsive element (Liu et al., 1996a) , we tested whether PML/ RARa directly aected the p21 promoter activity. PR9 cells were, therefore, electroporated with the WWP-luc construct, containing the cloned p21 promoter in front of the luciferase reporter gene, and either treated or not with Zn, to induce PML/RARa expression, and RA. As shown in Figure 3c (left panel), PML/RARa expression induced a strong (8 ± 10-fold) induction of the p21 promoter activity after RA-treatment. Notably, up-regulation of p21 activity was lost when the same p21-reporter gene was electroporated into P/ DR12 cells, a clone of U937 which expresses a PML/ RARa-mutant lacking the RARa DNA binding domain (Figure c, left panel) . That the eect of PML/RARa on p21 RNA is transcriptional and primary is further supported by the ®ndings that an inhibitor of RNA polymerases (actinomycin D) prevented up-regulation of p21 transcripts by RA and PML/RARa, while an inhibitor of protein synthesis (cycloheximide) did not ( Figure 3c , right panel). Taken together, these ®ndings indicate that p21 upregulation during RA treatment is an early event (2 ± 4 h) and is the direct consequence of the RARadependent transcriptional regulatory activity of PML/ RARa.
The RA-induced early p21 peak in PML/RARaexpressing cells occurs during the G1-S transition and is associated with increased CDK activity p21 was initially described as an inhibitor of cdk/cyclin complexes (Gu et al., 1993; Harper et al., 1993; Xiong et al., 1993) and as a mediator of the tumoursuppressor function of p53 (El-Deiry et al., 1993) . In agreement with this interpretation, p21 is up-regulated during the cell-cycle arrest associated with differentiation, quiescence and senescence (Macleod et al., 1995; Parker et al., 1995; Brown et al., 1997b) . It has been demonstrated that p21 can also be a component of active CDK complexes and participate in their assembly, depending on its relative cellular concentration (Zhang et al., 1994; LaBaer et al., 1997) . However, clear evidence for corresponding biological function is missing. In the model system presented here, it appears that p21 up-regulation by PML/RARa does not cause cell-cycle arrest, thereby pointing to other functions of p21 within the dierentiation process. To explore this possibility, we tested whether the high levels of p21 coincide with the G1-to S-phase transition, using synchronized cells, and measured the levels of CDK activity.
Highly enriched G1-cell populations (approximately 90%) were obtained by centrifugal elutriation of either PML/RARa expressing or non-expressing PR9 cells and were then treated with RA. p21 expression and cell-cycle pro®les were subsequently analysed every two hours for the duration of a cycle (16 h) by Western blotting and¯ow cytometry, respectively. p21 protein up-regulation was detectable, in PML/RARa expressing cells, after 2 h and became maximal after 6 h (Figure 4a ), just before most of the cells started to enter S-phase (Figure 4b ). This indicates that p21 upregulation does not induce cell cycle arrest, on the contrary, it is concomitant with G1 to S transition. As expected, the levels of p27, another CDK and cellcycle inhibitor (reviewed in Sherr and Roberts, 1995) , did not increase in PML/RARa-expressing cells; rather, a slight decrease of p27 was seen at the 8th and 10th hour, corresponding to the S-phase peak (Figure 4a) .
We then measured the histone H1 kinase activity of anti-CDK2 immunoprecipitates from PR9 cells, either expressing or not PML/RARa, prior to or after 4 and 8 h of RA-treatment (Figure 4c ). To assess complex assembly in the same lysates, we also examined coprecipitation of cyclin E, cyclin A and p21 with CDK2. In PML/RARa-expressing cells, p21 protein was undetectable in untreated cells and increased signi®cantly after 4 and 8 h of RA-treatment (see the anti-p21 Western blotting of the same lysates; Figure  4c ). In the presence of low concentrations of p21 (time 0 h; Zn-induced cells), low CDK activity was observed, while at higher levels of p21 (time-points 4 and 8 h; Zn-induced cells), CDK activity was signi®cantly higher (Figure 4c ). Both cyclin E (not shown), cyclin A and p21 polypeptides ( Figure 4c) were found in the anti-CDK2 immunoprecipitates, at higher levels in the 4th and 8th hour time-points. We notice that a slower migrating p21 polypeptide was present in the active CDK complexes at time 4 and 8 h (Figure 4c ). Since this p21 isoform has been demonstrated to be the consequence of hyperphosphorylation and to correlate with active cyclin/CDK complexes (Zhang et al., 1994) , these data suggest that p21 is part of active CDK complexes. Blotting the same anti-CDK2 immunoprecipitates with anti-CDK2 antibodies showed a similar amount of protein in all samples (Figure 4c) . Notably, the faster migrating anti-CDK2 immunoreactive polypeptide, corresponding to active CDK2 (Gu et al., 1992) , was more prominent in the PML/RARa expressing cells by 8 h than in the same cells before RA stimulation (Figure  4c ). High CDK activity correlated with the presence of hyperphosphorylated Rb in the same lysates (see the anti-Rb Western blotting in Figure 4c ). Taken together, these results indicate that, in the PML/ RARa-expressing cells, the high levels of p21 Figure 4a was not evident in other experiments), and 2 ± 3-fold increase after 4 and 8 h of RA treatment in the PML/RARa-expressing cells. In conclusion, early p21 up-regulation and CDK activation are part of the response of the parental U937 cells to RA. In PML/RARa-expressing U937 cells, however, these phenomena are markedly increased and correlate with commitment to terminal differentiation.
The late RA-induced p21 peak is associated with G1-arrest and low CDK activity in both PML/RARaexpressing and non-expressing cells
We then investigated the cell-cycle properties, p21 expression and CDK activity of PR9 cells during the late phases of RA-treatment (from the 2nd to the 4th day). The same experiment discussed in the previous paragraph (RA-treatment of G1-elutriated PR9 cells) was monitored beyond the 16th hour of culture, approximately every 12 h. Representative results of the 24th, 48th and 72 h are shown in Figure 4b and c. RA-treated PML/RARa expressing cells underwent a second round of cell cycle and then arrested in G1 by the 48th hour. PML/RARa Upper panels: Western blotting of p21 and RB expression in total cell lysates. Lower panels: Lysates from the indicated samples were immunoprecipitated with an a-CDK2 antibody, incubated on histone H1 in the presence of [ 32 P]gATP, run on a 15%SDS-PAGE and blotted. The same blot was then probed with a-CDK2, a-cycl A, and a-p21 antibodies. Left and right panels belong to separate experiments p21 and differentiation T Casini and PG Pelicci non-expressing cells, instead, entered into G1 by the 72nd hour (Figure 4b ). The intracellular levels of p21 in PML/RARa-expressing cells at the 48th hour, when cells are in post mitotic G1, were higher than at any earlier time-point and CDK activity was almost undetectable (Figure 4c ). In control cells, which at the same time point still proliferate ( Figure  4b ), p21 levels were low and some CDK activity was still detectable (Figure 4c ). At the 72nd hour, however, CDK activity was undetectable also in control cells and the levels of p21 were high and indistinguishable from those of PML/RARa-expressing cells (Figure 4c ). In summary, RA-treated PR9 cells entered into post mitotic G1 after two (PML/ RARa-expressing cells) or three (control cells) divisions. This G1 block was associated with a further p21 up-regulation, which reached similar levels in PML/RARa-expressing or non-expressing cells. Levels of CDK activity, however, were negligible in both samples. It therefore appears that G1-accumulation, late p21 up-regulation and inhibition of CDK activity are late events associated with the cellular response to RA and that they equally occur in PML/RARa and control cells, thereby suggesting that they are not involved in the commitment to dierentiation.
p21 up-regulation is indispensable for the eect of PML/ RARa on RA-mediated dierentiation
We then tested the eect of p21-depletion on PML/ RARa-driven dierentiation, by expressing an antisense p21 construct into PR9 cells. The p21 cDNA was cloned in the antisense (p21 As) orientation under the control of the 5' LTR of PINCO, a retroviral vector which expresses the Green Fluorescence Protein (GFP) from an internal CMV promoter (Grignani et al., 1998b) . Western blotting analysis of PINCO-p21 As infected PR9 cells showed a marked reduction of p21 expression after RA-treatment; in particular, antisense expression almost completely prevented the early p21 up-regulation (Figure 5c ; 6 h) and caused reduction to approximately 50% of the late, and more prominent, p21 peak (Figure 5c ; 96 h). Evaluation of RA-induced dierentiation in cells infected with either the control PINCO or PINCO-p21 As vectors was performed by double-¯uorescence FACS-analysis (see Materials and methods) of CD11a-expression levels in GFP-positive cells. Eciency of infection, as evaluated by the frequency of GFP-positive cells, varied from 70% (PINCO) to 50% (PINCO-p21-As). Results showed that, in the presence of p21-As, PML/RARa-mediated dierentiation was dramatically reduced (from 55 to Figure 5a) . Notably, concomitant cell-cycle analysis revealed no dierences related to the presence of the p21-As during RA-treatment, neither during the cycling period nor at the terminal G1-arrest (Figure 5b ).
In conclusion, these data demonstrate that early p21 up-regulation is indispensable for the PML/RARa eect on dierentiation. In addition, they suggest that: (i) the cell divisions associated with RA-induced dierentiation are not dependent on the early p21 upregulation, since they are maintained in cells expressing p21-As; and (ii) that the late p21 up-regulation and cell cycle arrest are not sucient for the dierentiation process to occur. It seems, therefore, that p21 plays two distinct roles during RA-response: early, on the dierentiation program, late, as inhibitor of the cell cycle.
Discussion
The main ®nding of this paper is the identi®cation of p21 as a downstream eector of PML/RARa during RA-induced dierentiation of APL cells; its main implication is the putative novel function of p21 as a regulatory protein of commitment to dierentiation in hematopoietic stem cells.
In response to the dierentiative stimulus of RA, PML/RARa-expressing cells undergo two rounds of cell division (Figures 2 and 4) and then enter post mitotic G1 (Figure 4) . The G1-to S phase transition of the ®rst cell cycle is required for the dierentiation process to occur (Figure 2 ) and coincides, in time, with the duration of commitment in the same cells ( Figure  1 ). Post mitotic G1 is a late event (Figure 4 ) and is not causally linked to the dierentiation process (i.e. RA can induce late G1 block without dierentiation, either in the presence or absence of the fusion protein; Figures 4 and 5) . Taken together, these results suggest a model for RA-induced dierentiation of APL cells where commitment occurs during the G1/S transition and does not depend on cell exit from the cell cycle, which, instead, appears to be a late component of the dierentiated phenotype.
RA-treatment of PML/RARa-expressing cells induced an early peak of both p21 protein expression and CDK activity, which coincided with the G1-S transition, and a subsequent, more pronounced peak of p21, with inactive CDK, which was associated with a late G1 block (Figure 4) . The early peak of p21 and CDK activity was much more pronounced in PML/RARa-expressing cells (where RA induces dierentiation and G1 arrest) than in the control cells (where RA induces G1 arrest without dierentiation), while the late p21 peak was similar in PML/RARa and control cells and in both cases it was associated with no detectable CDK activity (Figure 4) . Increased p21 and CDK activity in PML/RARa cells during G1-S had no eect on the percentage of cells entering into S and in the duration of the cell cycle (Figures 2 and 4) . Antisense p21 expression was sucient to reduce the early, but not the late, p21 peak and prevented RA-induced dierentiation of PML/RARa-expressing cells without altering the G1-S transition and the late G1 block ( Figure 5 ). It appears, therefore, that CDK activation and/or p21 play a crucial role during commitment to dierentiation, which is however independent of its eect on the cell cycle machinery. Subsequently, when cells enter into postmitotic G1, higher levels of p21 and inactive CDK might play a role in the entry and/or maintenance of quiescence.
Dierent mechanisms are probably responsible for the variations of p21 levels during RA-treatment of PML/RARa cells. Up-regulation of p21 expression during the G1/S transition is the direct consequence of PML/RARa expression. PML/RARa retains, in fact, the transactivating properties of the wild-type RARa (Figure 3 ) and the p21 promoter contains an RAresponsive element (Liu et al., 1996a) , strongly suggesting the p21 is a primary target gene of PML/ RARa. Up-regulation of p21 in post mitotic G1 cells, instead, is probably connected to the RA-induced G1 arrest, as suggested by the facts that it equally occurs in PML/RARa-expressing and control cells and that PML/RARa is no longer expressed at that time, due to its RA-induced degradation.
The variations in the enzymatic activity of CDK during RA-induced dierentiation of PML/RARaexpressing cells might be a direct consequence of the variations in the levels of p21 expression. It has been recently demonstrated that at low concentrations, p21 promotes the assembly of active kinase complexes, whereas at higher concentrations it inhibits their activity (Zhang et al., 1994; LaBaer et al., 1997) . Our results suggest that, in PML/RARa-cells, p21 is part of both the active and inactive cyclin-CDK complexes which form during the G1-S transition and G1 arrest, respectively. Therefore, the varying levels of p21 during RA-induced dierentiation of PML/RARa-cells might in¯uence the formation of kinase-active or -inactive cyclin-CDK-p21 complexes.
At the present moment, however, we do not know whether CDK activation is instrumental or accessory for p21 function and which are the mechanisms through which p21 and/or active CDK in¯uence commitment to dierentiation in PML/RARa-expressing cells. PCNA, Rb (Sherr and Roberts, 1995) , BMyb (Ziebold et al., 1997) , methyltransferase (Chuang et al., 1997), CDC6 (B Otzen-Petersen and K Helin, personal communication) are known targets of p21 or active CDK whose involvement should be evaluated. Interestingly, it has been recently shown that high levels of p21 inhibit recruitment of methyltransferase to DNA replication loci by competing its binding to PCNA. As a consequence, perpetuation of the methylated, i.e. transcriptionally repressed, state of genes, is prevented (Chuang et al., 1997) . This could provide an S phase dependent mechanism through which p21 might in¯uence gene expression in our system.
Our results raise the question whether the role of p21 and cell cycle transition during RA-and PML/ RARa-dependent dierentiation re¯ect a more general and physiological mechanism of commitment. Upregulation of p21 long before G1-arrest was reported in other dierentiating systems like MEL erythroleukemic (Macleod et al., 1995) , CMK megagaryoblastic (Matsumura et al., 1997) , and U937 (Liu et al., 1996b) cell lines. Experiments, however, were performed with asynchronous cell populations and p21 accumulation p21 and differentiation T Casini and PG Pelicci was generally interpreted in the context of its growth inhibitory function and G1 accumulation of the dierentiating cells. Alternatively, p21 accumulation might, also in those cases, occur during G1-S and be implicated in commitment. Indeed, many examples of dierentiation systems accompanied by cell-cycling have been reported; however cell division has been demonstrated to be indispensable for dierentiation in some (mating type switch in yeast; mammal developing neocortex; Friend leukemia cells) but not in other (myoblasts, TPA-treated HL-60 cells) cell systems (Rovera et al., 1980; Miller and Nasmyth, 1984; McConnell and Kaznowski, 1991; Spriggs et al., 1992 Skapek et al., 1995 . Mice with homozygous deletions of p21 (p21
) do not show gross defects in terminal dierentiation (Deng et al., 1995) , arguing against a general role of p21 in regulation of commitment/ dierentiation. The lack of such a phenotype, however, may be the consequence of redundancy of signals and/ or selective pressure during ontogenesis. In selected in vitro culture systems, indeed, evidences have been reported that suggest a role of p21 on dierentiation which is independent of its growth inhibitory eect. Keratinocytes de®cient for p21 or p27, a closely related CDK inhibitor, display increased proliferative potential; however, only p21 7/7 cells exhibit impairment of dierentiation (Missero et al., 1996) . Moreover, a role of p21 during terminal stages of dierentiation has been recently demonstrated in primary keratynocytes. Forced expression of p21 inhibits maturation of these cells and this inhibitory eect is lost with a carboxylterminal truncated p21 mutant, which however retains growth-inhibitory activity (Di Cunto et al., 1998) . In summary, our results, as well as a number of indirect experimental evidence, suggest that p21 might have a physiological function during the G1-S transition to regulate dierentiation commitment at least in some cell types.
Materials and methods

Cell culture conditions, infections and dierentiation assays
Cells were grown in RPMI hair 1640 and 10% calf serum, at a density of 0.25610 6 for the dierentiation assays. Mimosine was used at a concentration of 400 mM for 14 h on cells previously isoleucine-starved for 36 h; hydroxyurea was used for 20 h at 10 mM concentration. For retroviral infections, the amphotropic cell-line Phoenix was transfected with 5 mg of the PINCO or PINCO-p21As (containing the p21 ORF in an EcoRI fragment) vectors; supernatants were then used to infect PR9 cells with two rounds of centrifugation for two consecutive days (Grignani et al., 1998b) . Thirty-six h after the ®rst cycle of infection cells were treated with 100 mM ZnSO 4 and 12 h later induced with RA (10 76 M all-trans RA). Immunophenotyping with the aCD11a monoclonal antibody was performed with a phycoerythrin-conjugated secondary antibody and formaldehyde ®xation, when GFP-positively had to be simultaneously revealed, or with a¯uorescein-conjugated secondary antibody and methanol ®xation when accompanied by PI staining.
FACS analysis and centrifugal elutriation
Cells were ®xed for 30' in 70% methanol, stained with PI and analysed by¯ow cytometry on a Becton Dickinson FACScan. Variable amounts of exponentially growing cells, from 100 to 400610 6 , were resuspended in PBS plus 1% FBS, 0.3 mM EDTA, 0.1% w/v glucose and loaded in a JE-5.0 elutriation chamber, mounted on a Beckman J6-MC elutriator. Elutriation was performed at 258C, 2000 r.p.m., starting with an average speed of 12 ml/min and increasing by 3 ml/min to collect fractions.
Northern and Western blots, immunoprecipitations and kinase assays
Fifteen mg of total RNAs were electrophoresed on a 1% formaldehyde-agarose gel and transferred on Hybond N + membrane. Hybridization was performed in 50% formamide at 428C for 24 h with 32 P-labelled DNA probes followed by washes in 0.26SSC/0.1%SDS at 658C. Western blottings were performed on 100 mg of cellular lysates with a ± btubulin (Amersham), CP74 a-p21 (Dynlacht, 1997) and G3-245 a-RB (Pharmingen) monoclonal antibodies, and with the M2 a-CDK2, C-19 a-p27, H-432 a-cyclin A (Santa Cruz Inc), a-RARaF1 (Ruthardt et al., 1997) polyclonal antibodies. 500 mg of cell lysate were immunoprecipitated with 5 ml of M2 a-CDK2 antibody and the recovered immunocomplexes used for kinase assay using histone H1, as described (Xiong et al., 1993) .
Transient reporter transfections and luciferase assays
10
7 exponentially-growing U937-PR9 or -PDR12 cells were electroporated with a BioRad gene pulser II at 275V/0.4 cm, time constant 40, with 5 mg WWP-luc (El-Deiry et al., 1995), 2.5 mg CMV-b-Galactosidase and 5 mg PGEM3 as carrier. Fourteen hours after electroporation, cells were Zn-stimulated for 4 h, RA-treated for additional 8 h and lysed in a 1% Triton X-100, 1 mM DTT-containing phosphate buer pH 7.8. Luciferase activity was measured on a luciferin substrate provided by the Promega-luciferase assay system and read in an Anthos Lucy I ± spectrophotometer. Transfection eciency was normalized by the b-galactosidase assay.
